Skip to main content

Front Row Advisors LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1729254 TIBURON, CA

Position in REGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,247
-$298 QoQ
Shares Held
2
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,299
of 1,322 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Front Row Advisors LLC holds $551,277 across 11 Biotechnology names. REGN ranks #6 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 REGN
Regeneron Pharmaceuticals, Inc.
This page
2 $1,247

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,247 2
2026-03-31 $1,545 2
2025-12-31 $1,543 2
2025-09-30 $1,124 2
2025-06-30 $1,575 3
2025-03-31 $2,536 4
2024-12-31 $2,849 4
2024-09-30 $4,204 4
2024-06-30 $4,204 4
2024-03-31 $3,849 4
2023-12-31 $3,513 4
2023-09-30 $3,291 4
2023-06-30 $2,874 4
2023-03-31 $3,286 4
2022-09-30 $2,755 4
2022-06-30 $2,364 4
2022-03-31 $2,793 4
2021-12-31 $2,526 4
2021-09-30 $2,420 4
2021-06-30 $2,234 4
2021-03-31 $1,892 4
2020-12-31 $16,908 35
2020-09-30 $19,592 35
2020-06-30 $21,827 35
2020-03-31 $17,578 36